• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士多发性硬化症的高患病率。

High prevalence of multiple sclerosis in Switzerland.

作者信息

Beer S, Kesselring J

机构信息

Department of Neurology, Inselspital, Berne, Switzerland.

出版信息

Neuroepidemiology. 1994;13(1-2):14-8. doi: 10.1159/000110353.

DOI:10.1159/000110353
PMID:8190201
Abstract

Prevalence of multiple sclerosis (MS) was determined in the Canton of Berne, Switzerland. This canton is a geographically diverse region at 47 degrees northern latitude with 920,000 inhabitants. Epidemiological data were obtained from the case records of the University Department of Neurology, from the Swiss MS Society, from practising neurologists and from regional hospitals. Diagnostic accuracy was ascertained in retrospect, and only those cases fulfilling the criteria proposed by the Poser Committee were included. Of the patients provided by the Swiss MS Society, only those who had been diagnosed by a neurologist were accepted as definite cases. Changes of population due to migration or death were traced at governmental registry offices, and the place of residence was determined. Using the 1,016 cases of definite and probable MS identified, the minimal prevalence rate was 110 MS cases/100,000 inhabitants in the Canton of Berne on January 1, 1986. The increase in MS in this region since the 1950s was due mainly to the increase in life duration of MS patients rather than an increase in incidence rates over the last 20 years.

摘要

在瑞士伯尔尼州确定了多发性硬化症(MS)的患病率。该州是一个位于北纬47度、地域多样的地区,有92万居民。流行病学数据来自大学神经科的病例记录、瑞士多发性硬化症协会、执业神经科医生以及地区医院。回顾性地确定诊断准确性,仅纳入那些符合波泽委员会提出标准的病例。在瑞士多发性硬化症协会提供的患者中,只有那些由神经科医生诊断的患者被确认为确诊病例。通过政府登记处追踪因迁移或死亡导致的人口变化,并确定居住地。利用所确定的1016例确诊和可能的多发性硬化症病例,1986年1月1日伯尔尼州的最低患病率为每10万居民中有110例多发性硬化症病例。自20世纪50年代以来该地区多发性硬化症病例的增加主要是由于多发性硬化症患者寿命的延长,而非过去20年发病率的增加。

相似文献

1
High prevalence of multiple sclerosis in Switzerland.瑞士多发性硬化症的高患病率。
Neuroepidemiology. 1994;13(1-2):14-8. doi: 10.1159/000110353.
2
[Multiple sclerosis in the Bern canton (Switzerland). An epidemiologic study].[瑞士伯尔尼州的多发性硬化症。一项流行病学研究]
Fortschr Neurol Psychiatr. 1988 Dec;56(12):394-401. doi: 10.1055/s-2007-1001802.
3
Prevalence of multiple sclerosis in Flanders, Belgium.比利时弗拉芒地区多发性硬化症的患病率。
Neuroepidemiology. 1994;13(5):220-5. doi: 10.1159/000110383.
4
Clinical data bank at the University Department of Neurology, Bern, Switzerland: basis for an epidemiological study of multiple sclerosis in a high prevalence area.瑞士伯尔尼大学神经科临床数据库:高发病率地区多发性硬化症流行病学研究的基础。
Ital J Neurol Sci. 1987 Jun;Suppl 6:29-34.
5
A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.挪威霍达兰郡多发性硬化症发病率的50年随访研究。
Neurology. 2006 Jan 24;66(2):182-6. doi: 10.1212/01.wnl.0000195549.95448.b9.
6
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.奥普兰郡多发性硬化症的患病率和发病率:挪威东部一个内陆郡的横断面基于人群的研究。
Acta Neurol Scand. 2011 Oct;124(4):250-7. doi: 10.1111/j.1600-0404.2010.01465.x. Epub 2010 Dec 10.
7
Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.萨斯喀彻温省萨斯卡通市多发性硬化症的发病率和患病率
Neurology. 2007 Sep 18;69(12):1224-9. doi: 10.1212/01.wnl.0000276991.13764.77.
8
Incidence of multiple sclerosis in Dijon, France: a population-based ascertainment.法国第戎多发性硬化症的发病率:基于人群的确诊情况。
Neurol Res. 2000 Mar;22(2):156-9. doi: 10.1080/01616412.2000.11741053.
9
[Recording of multiple sclerosis in Swiss cause of death statistics. A 10-year mortality follow-up of the Bern prevalence study].
Soz Praventivmed. 1999;44(1):30-5. doi: 10.1007/BF01624808.
10
Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.希腊西部多发性硬化症的患病率和发病率:一项为期23年的调查。
Neuroepidemiology. 2008;30(3):167-73. doi: 10.1159/000122334. Epub 2008 Apr 2.

引用本文的文献

1
A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015.2006年至2015年巴伐利亚州多发性硬化症患病率、发病率及区域分布的系统评估
Front Neurol. 2018 Oct 30;9:871. doi: 10.3389/fneur.2018.00871. eCollection 2018.
2
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.基于 MRI 的支持向量机和病灶形态学预测临床孤立综合征向临床确诊多发性硬化的转化。
Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
3
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
瑞士多发性硬化症登记处(SMSR):一项参与性全国登记处的研究方案,以促进基于流行病学和以患者为中心的多发性硬化症研究。
BMC Neurol. 2018 Aug 13;18(1):111. doi: 10.1186/s12883-018-1118-0.
4
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011-2015.瑞士多发性硬化症的流行病学与成本:2011 - 2015年医疗保健索赔数据分析
Neuropsychiatr Dis Treat. 2017 Nov 1;13:2737-2745. doi: 10.2147/NDT.S143180. eCollection 2017.
5
Prevalence of chronic kidney disease in fabry disease patients: Multicenter cross sectional study in Argentina.法布里病患者慢性肾脏病的患病率:阿根廷的多中心横断面研究
Mol Genet Metab Rep. 2017 May 23;12:41-43. doi: 10.1016/j.ymgmr.2017.05.007. eCollection 2017 Sep.
6
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
7
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
8
Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment.轻度残疾多发性硬化症患者伴有或不伴有平衡障碍的躯干摆动。
Exp Brain Res. 2011 Sep;213(4):363-70. doi: 10.1007/s00221-011-2795-8. Epub 2011 Jul 20.
9
[Recording of multiple sclerosis in Swiss cause of death statistics. A 10-year mortality follow-up of the Bern prevalence study].
Soz Praventivmed. 1999;44(1):30-5. doi: 10.1007/BF01624808.